Recla, Elmera G.

HRN: 22-55-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
CEFUROXIME 750MG (VIAL)
01/30/2023
02/06/2023
IV
300mg
Q8
BFS; URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTICentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: